Pimozide — CAS 2062-78-4

Pimozide is a potent antipsychotic of the diphenylbutylpiperidine class used primarily in the treatment of Tourette syndrome and chronic schizophrenia. It works as a selective dopamine D2 receptor antagonist. Mediocon Inc manufactures Pimozide API at its GMP-certified facility in Aurangabad, Maharashtra, India.

• Treatment of Tourette syndrome (tic suppression)
• Management of chronic schizophrenia and delusional disorders
• Treatment of delusional parasitosis (Ekbom syndrome)
• Management of motor and vocal tics in Gilles de la Tourette syndrome

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support